» Articles » PMID: 15060529

AMP Kinase and Malonyl-CoA: Targets for Therapy of the Metabolic Syndrome

Overview
Specialty Pharmacology
Date 2004 Apr 3
PMID 15060529
Citations 156
Authors
Affiliations
Soon will be listed here.
Citing Articles

Potato protein hydrolysate (PPH902) exerts anti-lipogenesis and lipolysis-promoting effect by inhibiting adipogenesis in 3T3-L1 adipocytes.

Baskaran R, Chen Y, Chang C, Kuo H, Liang C, Abomughaid M 3 Biotech. 2025; 15(4):83.

PMID: 40078570 PMC: 11893942. DOI: 10.1007/s13205-025-04238-0.


New Insights into AMPK, as a Potential Therapeutic Target in Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatic Fibrosis.

An H, Jang Y, Choi J, Hur J, Kim S, Kwon Y Biomol Ther (Seoul). 2024; 33(1):18-38.

PMID: 39702310 PMC: 11704404. DOI: 10.4062/biomolther.2024.188.


The role and function of lncRNA in ageing-associated liver diseases.

Zarandi P, Ghiasi M, Heiat M RNA Biol. 2024; 22(1):1-8.

PMID: 39697114 PMC: 11660375. DOI: 10.1080/15476286.2024.2440678.


The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy.

Tang Y, Ju W, Liu Y, Deng Q Front Pharmacol. 2024; 15:1469830.

PMID: 39403142 PMC: 11471651. DOI: 10.3389/fphar.2024.1469830.


Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies.

Simon-Szabo L, Lizak B, Sturm G, Somogyi A, Takacs I, Nemeth Z Int J Mol Sci. 2024; 25(16).

PMID: 39201799 PMC: 11354764. DOI: 10.3390/ijms25169113.